# Identification of Multiple Pulmonary Diseases Using Volatile Organic Compounds Biomarkers in Human Exhaled Breath

> **NCT06528418** · — · RECRUITING · sponsor: **ChromX Health** · enrollment: 10000 (estimated)

## Conditions studied

- Lung Cancer
- Lung Infection
- COPD
- Bronchitis
- Pulmonary Fibrosis
- Pulmonary Embolism
- Pulmonary Arterial Hypertension
- Pulmonary Tuberculosis
- Pulmonary Abscess
- Emphysema
- Lung Injury
- Cystic Fibrosis of the Lung
- Bronchial Asthma
- Bronchiectasis
- Interstitial Lung Disease
- Preserved Ratio Impaired Spirometry

## Interventions

- **OTHER:** Gas chromatography-mass spectrometry(GC-MS) and micro Gas Chromatography-photoionisation detector (μGC-PID) system

## Key facts

- **NCT ID:** NCT06528418
- **Lead sponsor:** ChromX Health
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2024-06-30
- **Primary completion:** 2026-12-30
- **Final completion:** 2027-06-30
- **Target enrollment:** 10000 (ESTIMATED)
- **Last updated:** 2025-03-26

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06528418

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06528418, "Identification of Multiple Pulmonary Diseases Using Volatile Organic Compounds Biomarkers in Human Exhaled Breath". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06528418. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*